| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |